Oncocyte Appoints Andrea James as Chief Financial Officer
June 17, 2024 16:05 ET
|
OncoCyte Corporation
Oncocyte Appoints Seasoned Finance Executive Andrea James as Chief Financial Officer
Favorable Oncocyte VitaGraft Kidney Study Results Published in the New England Journal of Medicine
May 30, 2024 16:47 ET
|
OncoCyte Corporation
Late-breaking presentation of data at American Transplant Congress on Monday, June 3Data show potential to monitor for therapeutic efficacy and recurrencePotential repeat testing opportunities with...
Oncocyte Reports First Quarter 2024 Financial Results
May 15, 2024 16:05 ET
|
OncoCyte Corporation
ONCOCYTE REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS
Oncocyte to Announce First Quarter 2024 Financial Results
May 13, 2024 08:00 ET
|
OncoCyte Corporation
Oncocyte to Announce First Quarter 2024 Financial Results
Oncocyte Reports Full Year 2023 Financial Results
April 12, 2024 06:00 ET
|
OncoCyte Corporation
ONCOCYTE REPORTS FULL YEAR 2023 FINANCIAL RESULTS
Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules
April 11, 2024 21:46 ET
|
OncoCyte Corporation
Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules
Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay
April 11, 2024 17:30 ET
|
OncoCyte Corporation
Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay
Oncocyte to Announce Fourth Quarter and Full Year 2024 Financial Results
April 09, 2024 16:05 ET
|
OncoCyte Corporation
ONCOCYTE TO ANNOUNCE FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS
Oncocyte to Present at the Sequire Investor Summit in Puerto Rico
January 16, 2024 08:00 ET
|
OncoCyte Corporation
Oncocyte to Present at the Sequire Investor Summit in Puerto Rico
Oncocyte Begins FDA Submissions Process for VitaGraft Transplant Assays
December 06, 2023 08:00 ET
|
OncoCyte Corporation
- Significant unmet need for regulated product in $2B US testing market - Opportunity for expedited pathway for kitted product in development IRVINE, Calif., Dec. 06, 2023 (GLOBE NEWSWIRE) --...